IL70379A - Spiro-oxazolidones,-thiazolidones and-imidazolidones and pharmaceutical compositions containing them - Google Patents

Spiro-oxazolidones,-thiazolidones and-imidazolidones and pharmaceutical compositions containing them

Info

Publication number
IL70379A
IL70379A IL70379A IL7037983A IL70379A IL 70379 A IL70379 A IL 70379A IL 70379 A IL70379 A IL 70379A IL 7037983 A IL7037983 A IL 7037983A IL 70379 A IL70379 A IL 70379A
Authority
IL
Israel
Prior art keywords
thiazolidones
imidazolidones
oxazolidones
spiro
pharmaceutical compositions
Prior art date
Application number
IL70379A
Other languages
English (en)
Other versions
IL70379A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL70379A0 publication Critical patent/IL70379A0/xx
Publication of IL70379A publication Critical patent/IL70379A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL70379A 1982-12-06 1983-12-05 Spiro-oxazolidones,-thiazolidones and-imidazolidones and pharmaceutical compositions containing them IL70379A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44733782A 1982-12-06 1982-12-06
US06/545,450 US4556670A (en) 1982-12-06 1983-10-28 Spiro-3-hetero-azolones for treatment of diabetic complications

Publications (2)

Publication Number Publication Date
IL70379A0 IL70379A0 (en) 1984-03-30
IL70379A true IL70379A (en) 1988-10-31

Family

ID=27034944

Family Applications (1)

Application Number Title Priority Date Filing Date
IL70379A IL70379A (en) 1982-12-06 1983-12-05 Spiro-oxazolidones,-thiazolidones and-imidazolidones and pharmaceutical compositions containing them

Country Status (21)

Country Link
US (1) US4556670A (ko)
EP (1) EP0115133B1 (ko)
KR (1) KR860001581B1 (ko)
AU (1) AU545409B2 (ko)
BG (1) BG44708A3 (ko)
CA (1) CA1204763A (ko)
DD (1) DD219482A5 (ko)
DE (1) DE3379043D1 (ko)
DK (1) DK558283A (ko)
ES (1) ES8601912A1 (ko)
FI (1) FI80267C (ko)
GR (1) GR78787B (ko)
IE (1) IE56345B1 (ko)
IL (1) IL70379A (ko)
NO (1) NO160001C (ko)
NZ (1) NZ206484A (ko)
PH (1) PH19622A (ko)
PL (1) PL142143B1 (ko)
PT (1) PT77760B (ko)
RO (1) RO88202B (ko)
YU (1) YU43557B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3561198D1 (en) * 1984-03-23 1988-01-28 Pfizer Spiro-indenes and spiro-1,2-dihydro-naphthalenes for treatment of diabetic complications
US4575507A (en) 1985-05-29 1986-03-11 Pfizer Inc. Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use
GB8601100D0 (en) * 1986-01-17 1986-02-19 Cosmas Damian Ltd Drug delivery system
GB2355264A (en) 1999-09-30 2001-04-18 Merck & Co Inc Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists
AU2003225077A1 (en) 2002-04-18 2003-11-03 University Of Virginia Patent Foundation Novel sodium channel blockers
JP2006509015A (ja) * 2002-12-04 2006-03-16 メルク エンド カムパニー インコーポレーテッド スピロ環尿素、そのような化合物を含有する組成物、及び使用方法
JO3501B1 (ar) * 2014-12-22 2020-07-05 Servier Lab مشتقات 5-{(بيبرازين - 1-يل)-3-أوكسو - بروبيل}- إيميدازوليدين-2، 4 - دايون كمثبطات ل adamts لمعالجة هشاشة العظام)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2872454A (en) * 1959-02-03 Spiro-hydantoins from x-chloro-
GB796069A (en) * 1955-12-23 1958-06-04 Ici Ltd Substituted hydantoins
GB818724A (en) * 1956-10-18 1959-08-19 Ici Ltd Hydantoin derivatives
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3985888A (en) * 1969-07-24 1976-10-12 Richardson-Merrell Inc. Methods of inducing sedation using certain spiroalkanone-imides
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
US4181729A (en) * 1979-03-21 1980-01-01 Pfizer Inc. Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives
US4226875A (en) * 1979-04-02 1980-10-07 Pfizer Inc. Novel spiro-oxazolidinediones
US4307108A (en) * 1979-12-26 1981-12-22 Pfizer Inc. Method for lowering sorbitol levels using spiro-imides
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation

Also Published As

Publication number Publication date
US4556670A (en) 1985-12-03
PH19622A (en) 1986-05-30
YU43557B (en) 1989-08-31
CA1204763A (en) 1986-05-20
ES527780A0 (es) 1985-11-16
PT77760B (en) 1986-05-30
FI80267B (fi) 1990-01-31
DK558283D0 (da) 1983-12-05
DE3379043D1 (en) 1989-03-02
KR840006975A (ko) 1984-12-04
RO88202A (ro) 1985-12-30
YU237183A (en) 1986-02-28
ES8601912A1 (es) 1985-11-16
PT77760A (en) 1983-12-01
PL142143B1 (en) 1987-09-30
IE832854L (en) 1984-06-06
IE56345B1 (en) 1991-07-03
NO160001B (no) 1988-11-21
FI834457A0 (fi) 1983-12-05
IL70379A0 (en) 1984-03-30
NO160001C (no) 1989-03-01
BG44708A3 (ko) 1989-01-16
EP0115133B1 (en) 1989-01-25
FI80267C (fi) 1990-05-10
NZ206484A (en) 1987-07-31
FI834457A (fi) 1984-06-07
AU2196883A (en) 1984-06-14
AU545409B2 (en) 1985-07-11
NO834437L (no) 1984-06-07
DD219482A5 (de) 1985-03-06
DK558283A (da) 1984-07-11
KR860001581B1 (ko) 1986-10-10
GR78787B (ko) 1984-10-02
RO88202B (ro) 1985-12-31
PL244966A1 (en) 1985-05-21
EP0115133A1 (en) 1984-08-08

Similar Documents

Publication Publication Date Title
DE3372705D1 (en) Pharmaceutical composition and its use
IL74758A0 (en) Acyltripeptides and pharmaceutical compositions containing them
ZA834074B (en) Pharmaceutical composition
DE3168067D1 (en) 2-guanidino-4-heteroarylthiazoles and pharmaceutical compositions containing them
EP0093551A3 (en) Pharmaceutical composition
PH20168A (en) 7-carboxymethoxyphenylacetamino-3-cephem derivatives and their pharmaceutical compositions
GB2118176B (en) Pharmaceutical compositions
GB2117766B (en) Pharmaceutical compositions
NZ209095A (en) Piperidinoquinazolines and pharmaceutical compositions
IL64054A (en) Imidazolylpyridines and pharmaceutical compositions containing them
NZ208244A (en) Phenyl-pyrazol-3-ones and pharmaceutical compositions
IL70379A (en) Spiro-oxazolidones,-thiazolidones and-imidazolidones and pharmaceutical compositions containing them
GB8329700D0 (en) Anti-haemophilic pharmaceutical composition
PH19896A (en) 4-phenyl-tetrahydro-furano-pyridine and pharmaceutical compositions containing them
DE3377696D1 (en) Pharmaceutical compositions
NZ205732A (en) Thiatriazine derivatives and pharmaceutical compositions
GB8328896D0 (en) Pharmaceutical composition
GB2114001B (en) Nasel pharmaceutical compositions
IL68668A0 (en) Piperidinoquinazolines and pharmaceutical compositions containing them
NZ203649A (en) 2-beta-d-ribofuranosylselenazole-4-carboxamide derivatives and pharmaceutical compositions
IL74667A (en) Spiro-oxazolidones,-thiazolidones and-imidazolidones and pharmaceutical compositions containing them
ZA832811B (en) Azabicyclobenzamides their preparation and their pharmaceutical compositions
IL62146A (en) Guanylamidines and pharmaceutical compositions containing them
ZA814056B (en) Pharmaceutical bicyclo-octatriene compounds and compositions
DE3463383D1 (en) 4-alkylindolonaphthyridines and pharmaceutical compositions containing them